share_log

羚锐制药(600285.SH)部分董事、监事完成减持18.61万股

Some directors and supervisors of Ling Rui Pharmaceutical (600285.SH) completed a shareholding reduction of 1861,000 shares

Zhitong Finance ·  May 24 17:31

Ling Rui Pharmaceutical (600285.SH) announced that company director Wu Xizhen and supervisor Li Jin reduced their holdings of the company by a total of 18...

Zhitong Finance App News, Ling Rui Pharmaceutical (600285.SH) announced that company director Wu Xizhen and supervisor Li Jin reduced their holdings of the company's shares by a total of 1861,000 shares, and the implementation of this holdings reduction plan has been completed.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment